Matthijs M. Jore
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
The kinetics and transmission-blocking dynamics of P. falciparum sexual-stage antibody responses in a six-year cohort of Ugandan children and adults.
Journal: Research square
Published: February 23, 2026
Pfs230 domain 12 is a potent malaria transmission-blocking vaccine candidate.
Journal: Science advances
Published: November 07, 2025
BioMalPar at 21 - a coming of age for malaria research and interventions.
Journal: Trends in parasitology
Published: July 13, 2025
A stabilized tandem antigen chimera that elicits potent malaria transmission-reducing activity.
Journal: Nature communications
Published: June 22, 2025
Cryo-EM structure of endogenous Pfs230:Pfs48/45 complex with six antibodies reveals mechanisms of malaria transmission-blocking activity.
Journal: Immunity
Published: June 13, 2025
Structure of endogenous Pfs230:Pfs48/45 in complex with potent malaria transmission-blocking antibodies.
Journal: bioRxiv : the preprint server for biology
Published: February 24, 2025
Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross-stage recognition of glutamate-rich repeats.
Journal: eLife
Published: January 16, 2025
Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions.
Journal: Immunological reviews
Published: December 26, 2024
A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles enhances the immunogenicity of the malaria antigen Pfs25.
Journal: Nature nanotechnology
Published: January 25, 2024
Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross stage recognition of glutamate-rich repeats.
Journal: bioRxiv : the preprint server for biology
Published: November 14, 2023
Structural elucidation of full-length Pfs48/45 in complex with potent monoclonal antibodies isolated from a naturally exposed individual.
Journal: Nature structural & molecular biology
Published: November 13, 2023
Last Updated: 09/26/2026